Laboratorio Banco Vida – FDA 483, Aug 12, 2021
Laboratorio Banco Vida in San Juan, PR, a human tissue establishment, was cited for three observations during an FDA inspection. The firm failed to adequately validate processing methods to reduce the risk of communicable disease transmission by HCT/Ps and did not properly investigate deviations related to microbial contamination in umbilical cord blood tissues. Additionally, the firm lacked documented procedures for handling microbial growth and failed to update manufacturing procedures with necessary corrective actions.
ID · 00d64678-5abe-49e8-9280-af7810ee2ef3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.